CELH
Celsius Holdings, Inc.
CELH has the edge over HELE overall, supported by stronger valuation and stronger fundamentals.
HELE
Helen of Troy Limited
HELE's outlook is improving, though it still trails on the overall score.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
HELE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Weak |
HELE's cash flow is currently healthy, and its revenue and profitability are stable, but its balance sheet is weak.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
HELE PE Valuation
HELE has no meaningful PE right now: it lost money over the past year.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CELH has the edge over HELE on the outlook, with more favorable revenue expectations.
HELE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| Low |
Analysts expect HELE's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH has the edge over HELE on earnings quality, reporting a profit while its opponent remains loss making.
HELE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.84 | — |
| Q3 2026 | -$4.29 | +$24.43 |
| Q2 2026 | -$17.92 | -$3.38 |
| Q1 2026 | -$39.08 | -828% |
| Q4 2025 | -$34.54 | -801% |
| Q3 2025 | -$28.72 | -583% |
| Q2 2025 | -$14.54 | -329% |
| Q1 2025 | $5.37 | -24% |
| Q4 2024 | $4.93 | -27% |
HELE lost $4.29 per share over the past year, a smaller loss than the year before.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over HELE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over HELE on profitability, with a higher operating margin.
HELE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $440.9M | +2.1% |
| Q2 2026 | $402.1M | +8.2% |
| Q1 2026 | $470M | -3.3% |
| Q4 2025 | $512.8M | -3.4% |
| Q3 2025 | $431.8M | -8.9% |
| Q2 2025 | $371.7M | -11% |
| Q1 2025 | $485.9M | -0.7% |
| Q4 2024 | $530.7M | -3.4% |
HELE's revenue fell from its 2020 peak and has held roughly level since: $441M last quarter, up 2.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.2% | +78 points |
| Q2 2026 | 15% | +125 points |
| Q1 2026 | -11% | -11 points |
| Q4 2025 | -1.6% | -16 points |
| Q3 2025 | -73% | -81 points |
| Q2 2025 | -110% | -117 points |
| Q1 2025 | 0.4% | -13 points |
| Q4 2024 | 14% | -5.3 points |
HELE's operating margin was 5.2% last quarter, up 78 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
HELE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $44.8M | +$66.7M |
| Q2 2026 | -$6.4M | -114% |
| Q1 2026 | $103.1M | +281% |
| Q4 2025 | $5.8M | +2921% |
| Q3 2025 | -$21.9M | -155% |
| Q2 2025 | $45M | +178% |
| Q1 2025 | $27.1M | -59% |
| Q4 2024 | $191K | -100% |
HELE still generates free cash flow, though less than at its 2020 peak: $147M over the past year.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over HELE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
HELE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.7% | +395K shares |
| 1 year | +5.2% | +1.2M shares |
| 3 years | +0.5% | +112K shares |
| 5 years | -0.8% | -194K shares |
| Available history | -4.9% | -1.2M shares |
HELE has 24M diluted shares, up 5.2% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $47,000 |
| Q2 2026 | $1.2M |
| Q1 2026 | $209,000 |
| Q4 2025 | $224,000 |
| Q3 2025 | $151,000 |
| Q2 2025 | $1.3M |
| Q1 2025 | $14,000 |
| Q4 2024 | $30,000 |
HELE spent $2M buying back its own shares over the past year, up 11% from the year before.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has the edge over HELE on leverage, with a lower net debt burden relative to earnings.
HELE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 8.5x | High |
| Q1 2025 | 4.5x | High |
| Q4 2024 | 2.6x | Moderate |
| Q3 2024 | 2.4x | Moderate |
| Q2 2024 | 2.4x | Moderate |
| Q1 2024 | 2.1x | Moderate |
| Q4 2023 | 2.4x | Moderate |
| Q3 2023 | 3.1x | Elevated |
HELE's net debt is about 8.5 years of its operating earnings (EBITDA), up from 2.4 years a year ago.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
HELE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 70.0 | Neutral |
| Stochastic | 78.3 | Neutral |
HELE's weekly RSI is 70 (neutral) and its Stochastic is 78 (neutral).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
HELE PE vs Consumer Defensive Sector
| Metric | HELE | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 19x | — |
HELE has no meaningful PE right now: it lost money over the past year.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
HELE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $30.3 | 23% above |
| 20 week MA | $29.0 | 28% above |
| 50 week MA | $24.0 | 55% above |
| 100 week MA | $29.6 | 25% above |
| 200 week MA | $63.9 | 42% below |
HELE has the edge over CELH on trend strength, trading above more of its moving averages.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
HELE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $179.9 | $224.8 | +25% |
| 2021 | $224.8 | $245.4 | +9.1% |
| 2022 | $245.4 | $103.7 | -58% |
| 2023 | $103.7 | $120.8 | +17% |
| 2024 | $120.8 | $60.5 | -50% |
| 2025 | $60.5 | $21.1 | -65% |
| 2026 YTD | $21.1 | $37.2 | +76% |
HELE has the edge over CELH on returns for 2026, with the stronger performance.